Kiichi Adachi
Fortune : 220 769 $ au 30/06/2026
Fortune : 220 769 $ au 30/06/2026
Kiichi Adachi is currently the President, CEO & Representative Director at Kringle Pharma, Inc. He previously worked as a Research Scientist at Cogenics Icoria, Inc. and as a Chief Scientist at Mitsui & Co. Global Strategic Studies Institute.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
KRINGLE PHARMA, INC. 1,29 % | 31/03/2026 | 108 400 ( 1,29 % ) | 220 769 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| KRINGLE PHARMA, INC. | Directeur Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
Mitsui & Co. Global Strategic Studies Institute
Mitsui & Co. Global Strategic Studies Institute Miscellaneous Commercial ServicesCommercial Services Operates research institute | Directeur Technique/Scientifique/R&D | - |
Cogenics Icoria, Inc.
Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Cogenics Icoria, Inc.
Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
Mitsui & Co. Global Strategic Studies Institute
Mitsui & Co. Global Strategic Studies Institute Miscellaneous Commercial ServicesCommercial Services Operates research institute | Commercial Services |
Kringle Pharma, Inc.
Kringle Pharma, Inc. BiotechnologyHealth Technology Researches and develops treatments for regenerative medicine and cancer therapy | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national